Top Companies in Patient Monitoring Devices Market

The patient monitoring devices market is projected to reach USD 76.11 billion by 2031 from USD 55.60 billion in 2026, growing at a CAGR of 6.4%.

Patient monitoring devices have become a critical component of modern healthcare systems, enabling continuous assessment of vital health parameters such as heart rate, blood pressure, oxygen saturation, respiratory rate, and neurological activity across diverse care environments. The market encompasses a broad range of product categories, including multiparameter monitors, glucose continuous monitoring (CGM) systems, wearable monitoring devices, EEG, EMG, ICP, ECG, implantable loop recorders (ILR), mobile cardiac telemetry (MCT), pulse oximeters, fetal and neonatal monitors, blood pressure monitors, hemodynamic monitoring systems, spirometers, and capnography devices. Increasing prevalence of chronic diseases, rising incidence of cardiovascular and respiratory disorders, and growing demand for continuous patient surveillance are significantly accelerating adoption. Additionally, expanding utilization across hospitals, intensive care units (ICUs), ambulatory surgical centers (ASCs), and home healthcare settings is creating sustained demand for advanced monitoring technologies. The integration of wireless connectivity, wearable sensors, and AI-driven analytics further enhances real-time clinical decision-making and patient outcomes. As healthcare providers increasingly prioritize early diagnosis, remote monitoring, and preventive care, investments in advanced patient monitoring systems continue to rise across regions, making these devices a key contributor to long-term growth in the healthcare market.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in this market include Medtronic Plc. (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Masimo Corporation (US), Omron Corporation (Japan), ARCHIMED SAS (Natus Medical) (France), Compumedics Limited (Australia), and Nonin Medical, Inc. (US).

GE HealthCare (US)

GE HealthCare’s position in the patient monitoring devices market is driven by its comprehensive portfolio of advanced monitoring solutions and strong expertise in connected healthcare technologies. The company offers a broad range of patient monitoring systems, including multiparameter monitors, telemetry solutions, maternal and fetal monitoring devices, and remote patient monitoring platforms used across hospitals, intensive care units (ICUs), emergency departments, and ambulatory care settings. It benefits from a strong global presence and an extensive distribution network, serving healthcare providers across developed and emerging markets. Its client base includes hospitals, specialty clinics, outpatient centers, and home healthcare providers, reinforcing its reputation as a leading provider of innovative, reliable, and integrated patient monitoring solutions.

Medtronic Plc. (Ireland)

Medtronic Plc.’s position in the patient monitoring devices market is supported by its extensive acute care and monitoring portfolio, strong connected-care capabilities, and broad clinical expertise. The company offers solutions including pulse oximetry, capnography, brain monitoring, wearable devices, and remote patient monitoring systems used across hospitals, ICUs, surgical settings, and home-care environments. Backed by a strong global footprint, healthcare partnerships, and continuous innovation in connected health technologies, Medtronic maintains a leading position in delivering integrated patient monitoring solutions worldwide.

Abbott Laboratories (US)

Abbott Laboratories’ position in the patient monitoring devices market is driven by its strong portfolio of continuous and connected monitoring technologies, particularly in glucose monitoring and cardiac care. The company offers patient monitoring solutions, including continuous glucose monitoring (CGM) systems, cardiac rhythm monitoring devices, and remote patient monitoring technologies used in hospitals, clinics, and home care settings. Supported by globally recognized platforms, strong healthcare partnerships, and continued innovation in digital and wearable health technologies, Abbott maintains a strong position in delivering patient-centric monitoring solutions worldwide.

Market Ranking

The patient monitoring devices market is highly competitive, with prominent players accounting for a 70-72% share of the total market in 2026. Some players dominating the market include Medtronic Plc. (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), and Nihon Kohden Corporation (Japan).

The patient monitoring devices market is characterized by growing opportunities driven by the rising prevalence of chronic diseases, increasing aging populations, and expanding healthcare infrastructure across regions such as Asia-Pacific and North America. Market participants in countries including China, India, Japan, and South Korea are strengthening their presence through cost-effective solutions, localized manufacturing capabilities, and expansion of connected healthcare technologies.

The rising incidence of cardiovascular disorders, diabetes, and respiratory diseases, along with the growing demand for continuous patient surveillance, is driving adoption of these technologies across hospitals, intensive care units (ICUs), ambulatory surgical centers, and home care settings. Market players are focusing on improving device accuracy, portability, wireless connectivity, and interoperability to address evolving healthcare needs. Additionally, technological advancements such as wearable monitoring devices, AI-enabled analytics, remote patient monitoring platforms, and cloud-based healthcare integration are encouraging companies to accelerate product innovation and strengthen their competitive positioning in the global patient monitoring devices market.

Related Reports:

Patient Monitoring Devices Market By Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]